[Federal Register Volume 81, Number 154 (Wednesday, August 10, 2016)]
[Notices]
[Pages 52908-52909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18921]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by-the Drug Enforcement Administration (DEA) as bulk
manufacturers of various classes of controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as manufacturers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted for these
notices.
[[Page 52909]]
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
Noramco, Inc.................... 81 FR 7587........ February 12, 2016.
Cayman Chemical Company......... 81 FR 9217........ February 24, 2016.
Janssen Pharmaceutical, Inc..... 81 FR 9219........ February 24, 2016.
Insys Therapeutics, Inc......... 81 FR 9220........ February 24, 2016.
Siemens Healthcare Diagnostics, 81 FR 15565....... March 23, 2016.
Inc..
Siegfried USA, LLC.............. 81 FR 15567....... March 23, 2016.
Patheon Pharmaceuticals, Inc.... 81 FR 15571....... March 23, 2016.
Navinta, LLC.................... 81 FR 20418....... April 7, 2016.
Patheon API Manufacturing, Inc.. 81 FR 22122....... April 14, 2016.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of these registrants to manufacture
the applicable basic classes of controlled substances is consistent
with the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each of the company's maintenance of
effective controls against diversion by inspecting and testing each
company's physical security systems, verifying each company's
compliance with state and local laws, and reviewing each company's
background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed persons.
Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-18921 Filed 8-9-16; 8:45 am]
BILLING CODE 4410-09-P